Insider Trading activities at Illumina, Inc. (ILMN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Illumina, Inc. (ILMN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Illumina, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1110803.

Total stock buying since 2005: $2,748,194.
Total stock sales since 2005: $1,191,574,365.
Total stock option exercises since 2005: $187,225,090.


49 insiders reported insider trading activities at Illumina, Inc. (ILMN):
Insider trading activities of Febbo Phillip G.
Insider trading activities of Ronaghi Mostafa
Insider trading activities of Orpin Tristan
Insider trading activities of Douglas David C
Insider trading activities of Cabral Paulette D
Insider trading activities of Barker David L
Insider trading activities of Aravanis Alexander
Insider trading activities of Naclerio Nicholas
Insider trading activities of Ragusa Robert P
Insider trading activities of Dorsa Caroline
Insider trading activities of Heath Gregory
Insider trading activities of Bradbury Daniel
Insider trading activities of Pegels Kevin Carl
Insider trading activities of Eastham Karin
Insider trading activities of Thaysen Jacob
Insider trading activities of Mcginnis Karen K
Insider trading activities of Cabou Christian
Insider trading activities of Dhingra Ankur
Insider trading activities of Bowman A Blaine
Insider trading activities of Moeller Gerald
Insider trading activities of Epstein Robert S
Insider trading activities of Tousi Susan H
Insider trading activities of Goswami Joydeep
Insider trading activities of West John
Insider trading activities of Stuelpnagel John R
Insider trading activities of Hoyt Aimee L
Insider trading activities of Arnold Frances
Insider trading activities of Henry Christian O
Insider trading activities of Stapley Marc
Insider trading activities of Goldstein Jack
Insider trading activities of Desouza Francis A
Insider trading activities of Van Oene Mark
Insider trading activities of Grint Paul C
Insider trading activities of Whitfield Roy A
Insider trading activities of Dadswell Charles
Insider trading activities of Ostadan Omead
Insider trading activities of Walt David R
Insider trading activities of Reeves Kathryne Gambrell
Insider trading activities of Kain Robert C
Insider trading activities of Kersey Alan
Insider trading activities of Mccomb Joel
Insider trading activities of Flatley Jay T
Insider trading activities of Posard Matthew L.
Insider trading activities of Bianchi Paul L
Insider trading activities of Bouchard Michel
Insider trading activities of Lewis Mark L
Insider trading activities of Rastetter William H
Insider trading activities of Klausner Richard
Insider trading activities of Samad Sam

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Illumina, Inc. (ILMN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 18,450 $1,500,027 0 $0 0 $0
2024 7,330 $996,344 0 $0 0 $0
2023 0 $0 11,630 $2,288,888 68,902 $540,284
2022 0 $0 6,787 $2,313,640 38,110 $0
2021 0 $0 76,862 $32,133,367 53,748 $0
2020 0 $0 153,063 $51,235,027 107,230 $0
2019 0 $0 166,043 $51,488,681 148,450 $4,489,250
2018 0 $0 207,105 $59,766,035 152,950 $3,491,285
2017 0 $0 455,648 $88,829,978 425,871 $21,632,278
2016 0 $0 304,789 $48,921,636 545,401 $8,014,616
2015 0 $0 1,117,701 $221,793,291 753,395 $24,718,407
2014 0 $0 1,302,250 $215,660,563 1,262,640 $37,615,935
2013 0 $0 1,596,048 $118,377,128 1,492,387 $40,207,436
2012 1,217 $47,458 186,591 $9,547,988 206,000 $3,823,781
2011 4,839 $204,365 793,264 $55,004,833 780,467 $11,494,144
2010 0 $0 1,462,467 $65,282,978 1,178,143 $16,880,360
2009 0 $0 948,051 $34,070,305 524,296 $4,030,889
2008 0 $0 999,177 $62,564,210 426,200 $4,917,923
2007 0 $0 1,065,401 $47,966,087 533,039 $5,235,340
2006 0 $0 553,233 $17,611,673 28,700 $133,162
2005 0 $0 546,352 $6,718,057 0 $0

Table 2. Monthly summary of insider trading at Illumina, Inc. (ILMN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-05 18,450 $1,500,027 0 $0 0 $0
2024-02 7,330 $996,344 0 $0 0 $0
2023-11 0 $0 315 $35,544 0 $0
2023-08 0 $0 500 $83,520 0 $0
2023-07 0 $0 500 $95,040 0 $0
2023-06 0 $0 500 $100,000 0 $0
2023-05 0 $0 0 $0 7,600 $540,284
2023-03 0 $0 3,917 $779,737 0 $0
2023-02 0 $0 5,898 $1,195,047 61,302 $0
2022-07 0 $0 539 $107,800 0 $0
2022-06 0 $0 250 $53,712 0 $0
2022-04 0 $0 4,830 $1,685,967 0 $0
2022-03 0 $0 368 $126,161 0 $0
2022-02 0 $0 0 $0 38,110 $0
2022-01 0 $0 800 $340,000 0 $0
2021-12 0 $0 522 $198,659 0 $0
2021-11 0 $0 4,601 $1,873,268 0 $0
2021-10 0 $0 9,192 $3,812,854 0 $0
2021-09 0 $0 414 $178,924 0 $0
2021-08 0 $0 1,986 $978,627 0 $0
2021-07 0 $0 1,153 $554,764 0 $0
2021-06 0 $0 3,300 $1,503,798 0 $0
2021-05 0 $0 8,300 $3,169,284 0 $0
2021-04 0 $0 11,114 $4,565,067 0 $0

Table 3. Detailed insider trading at Illumina, Inc. (ILMN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-05-13 Thaysen Jacob (Chief Executive Officer) Buy 5,850 81.51 476,815
2025-05-12 Dhingra Ankur (SVP, Chief Financial Officer) Buy 6,100 81.21 495,380
2025-05-12 Thaysen Jacob (Chief Executive Officer) Buy 6,500 81.20 527,832
2024-02-22 Thaysen Jacob (Chief Executive Officer) Buy 7,330 135.93 996,344
2023-11-07 Hoyt Aimee L (SVP, Chief People Officer) Sale 315 112.84 35,544
2023-08-22 Tousi Susan H (SVP, Chief Commercial Officer) Sale 500 167.04 83,520
2023-07-24 Tousi Susan H (SVP, Chief Commercial Officer) Sale 500 190.08 95,040
2023-06-22 Tousi Susan H (SVP, Chief Commercial Officer) Sale 500 200.00 100,000
2023-05-25 Epstein Robert S (Director) Option Ex 7,600 71.09 540,284
2023-03-01 Hoyt Aimee L (SVP, Chief People Officer) Sale 3,917 199.06 779,737
2023-02-22 Aravanis Alexander (SVP, Chief Technology Officer) Sale 5,398 201.79 1,089,262
2023-02-21 Pegels Kevin Carl (Chief of Global Operations) Option Ex 1,097 .00 0
2023-02-21 Reeves Kathryne Gambrell (SVP, Chief Marketing Officer) Option Ex 2,789 .00 0
2023-02-21 Aravanis Alexander (SVP, Chief Technology Officer) Option Ex 9,292 .00 0
2023-02-21 Tousi Susan H (SVP, Chief Commercial Officer) Option Ex 5,869 .00 0
2023-02-21 Hoyt Aimee L (SVP, Chief People Officer) Option Ex 5,282 .00 0
2023-02-21 Febbo Phillip G. (SVP Chief Medical Officer) Option Ex 3,522 .00 0
2023-02-21 Dadswell Charles (SVP & General Counsel) Option Ex 5,282 .00 0
2023-02-21 Goswami Joydeep (SVP Chief Financial Officer) Option Ex 4,696 .00 0
2023-02-21 Desouza Francis A (President and CEO) Option Ex 23,473 .00 0
2023-02-06 Tousi Susan H (SVP, Chief Commercial Officer) Sale 500 211.57 105,785
2022-07-07 Aravanis Alexander (SVP, Chief Technology Officer) Sale 539 200.00 107,800
2022-06-10 Tousi Susan H (SVP, Chief Commercial Officer) Sale 250 214.85 53,712
2022-04-28 Dadswell Charles (SVP & General Counsel) Sale 368 300.13 110,447
2022-04-12 Hoyt Aimee L (SVP, Chief People Officer) Sale 2,474 347.54 859,821
2022-04-06 Febbo Phillip G. (SVP Chief Medical Officer) Sale 1,988 360.01 715,699
2022-03-28 Dadswell Charles (SVP & General Counsel) Sale 368 342.83 126,161
2022-02-22 Pegels Kevin Carl (Chief of Global Operations) Option Ex 1,065 .00 0
2022-02-22 Tousi Susan H (SVP, Chief Commercial Officer) Option Ex 4,561 .00 0
2022-02-22 Samad Sam (SVP and CFO) Option Ex 4,561 .00 0
2022-02-22 Dadswell Charles (SVP & General Counsel) Option Ex 4,561 .00 0
2022-02-22 Goswami Joydeep (SVP Corp Business Development) Option Ex 3,979 .00 0
2022-02-22 Desouza Francis A (President and CEO) Option Ex 19,383 .00 0
2022-01-12 Tousi Susan H (SVP, Chief Commercial Officer) Sale 800 425.00 340,000
2021-12-28 Tousi Susan H (SVP, Chief Commercial Officer) Sale 100 387.06 38,706
2021-12-22 Dadswell Charles (SVP & General Counsel) Sale 322 380.29 122,453
2021-12-08 Tousi Susan H (SVP, Chief Commercial Officer) Sale 100 375.00 37,500
2021-11-22 Dadswell Charles (SVP, General Counsel) Sale 314 377.86 118,648
2021-11-12 Aravanis Alexander (SVP, Chief Technology Officer) Sale 361 386.35 139,472
2021-11-08 Febbo Phillip G. (SVP Chief Medical Officer) Sale 1,000 406.83 406,830
2021-11-02 Aravanis Alexander (SVP, Chief Technology Officer) Sale 2,926 412.96 1,208,318
2021-10-28 Tousi Susan H (SVP, Chief Commercial Officer) Sale 100 414.35 41,435
2021-10-26 Aravanis Alexander (SVP, Chief Technology Officer) Sale 2,926 423.00 1,237,698
2021-10-22 Dadswell Charles (SVP & General Counsel) Sale 314 411.00 129,054
2021-10-19 Aravanis Alexander (SVP, Chief Technology Officer) Sale 2,926 412.46 1,206,857
2021-10-12 Aravanis Alexander (SVP, Chief Technology Officer) Sale 2,926 409.37 1,197,810
2021-09-28 Tousi Susan H (SVP, Chief Commercial Officer) Sale 100 418.04 41,804
2021-09-22 Dadswell Charles (SVP & General Counsel) Sale 314 436.69 137,120
2021-08-30 Tousi Susan H (SVP, Chief Commercial Officer) Sale 300 463.50 139,050
2021-08-23 Dadswell Charles (SVP & General Counsel) Sale 314 489.10 153,577
2021-08-04 Tousi Susan H (SVP, Chief Commercial Officer) Sale 1,000 500.00 500,000
2021-08-04 Hoyt Aimee L (SVP, Chief People Officer) Sale 372 500.00 186,000
2021-07-28 Tousi Susan H (SVP, Chief Commercial Officer) Sale 300 486.41 145,923
2021-07-22 Dadswell Charles (SVP & General Counsel) Sale 314 482.23 151,420
2021-07-07 Aravanis Alexander (SVP, Chief Technology Officer) Sale 539 477.59 257,421
2021-06-28 Tousi Susan H (SVP, Chief Commercial Officer) Sale 300 478.95 143,685
2021-06-24 Hoyt Aimee L (SVP, Chief People Officer) Sale 500 475.00 237,500
2021-06-11 Febbo Phillip G. (SVP Chief Medical Officer) Sale 1,000 447.61 447,613
2021-06-10 Hoyt Aimee L (SVP, Chief People Officer) Sale 500 450.00 225,000
2021-06-10 Dorsa Caroline (Director) Sale 1,000 450.00 450,000
2021-05-18 Flatley Jay T (Director) Sale 4,000 379.53 1,518,120
2021-05-05 Tousi Susan H (SVP Product Development) Sale 300 381.88 114,564
2021-05-04 Flatley Jay T (Director) Sale 4,000 384.15 1,536,600
2021-04-22 Dadswell Charles (SVP & General Counsel) Sale 314 402.02 126,234
2021-04-20 Flatley Jay T (Director) Sale 4,000 401.83 1,607,320
2021-04-06 Tousi Susan H (SVP Product Development) Sale 500 423.44 211,717
2021-04-06 Hoyt Aimee L (SVP, Chief People Officer) Sale 1,000 424.22 424,218
2021-04-06 Flatley Jay T (Director) Sale 4,000 423.44 1,693,740
2021-04-05 Tousi Susan H (SVP Product Development) Sale 300 386.03 115,808
2021-04-05 Hoyt Aimee L (SVP, Chief People Officer) Sale 1,000 386.03 386,030
2021-03-22 Dadswell Charles (SVP & General Counsel) Sale 314 416.24 130,699
2021-03-16 Flatley Jay T (Director) Sale 4,000 421.06 1,684,240
2021-03-05 Tousi Susan H (SVP Product Development) Sale 800 402.24 321,792
2021-03-02 Flatley Jay T (Director) Sale 4,000 444.61 1,778,440
2021-02-18 Mcginnis Karen K (VP, Chief Accounting Officer) Sale 666 486.75 324,175
2021-02-17 Tousi Susan H (SVP Product Development) Option Ex 6,306 .00 0
2021-02-17 Hoyt Aimee L (SVP, Chief People Officer) Option Ex 4,625 .00 0
2021-02-17 Samad Sam (SVP and CFO) Option Ex 4,379 .00 0
2021-02-17 Febbo Phillip G. (SVP Chief Medical Officer) Option Ex 3,173 .00 0
2021-02-17 Dadswell Charles (SVP & General Counsel) Option Ex 3,503 .00 0
2021-02-17 Desouza Francis A (President and CEO) Option Ex 24,521 .00 0
2021-02-17 Ragusa Robert P (SVP, Global Quality & Ops) Option Ex 6,306 .00 0
2021-02-17 Mcginnis Karen K (VP, Chief Accounting Officer) Option Ex 935 .00 0
2021-02-16 Flatley Jay T (Director) Sale 4,500 498.48 2,243,146
2021-02-05 Tousi Susan H (SVP Product Development) Sale 800 431.90 345,520
2021-02-02 Hoyt Aimee L (SVP, Chief People Officer) Sale 57 444.84 25,355
2021-02-02 Flatley Jay T (Director) Sale 4,000 444.84 1,779,360
2021-02-02 Mcginnis Karen K (VP, Chief Accounting Officer) Sale 72 444.84 32,028
2021-02-01 Desouza Francis A (President and CEO) Sale 3,000 439.46 1,318,368
2021-01-20 Tousi Susan H (SVP Product Development) Sale 2,500 400.00 1,000,000
2021-01-19 Flatley Jay T (Director) Sale 4,000 382.48 1,529,920
2021-01-11 Hoyt Aimee L (SVP, Chief People Officer) Sale 271 379.65 102,885
2021-01-05 Tousi Susan H (SVP Product Development) Sale 300 365.27 109,581
2021-01-05 Flatley Jay T (Director) Sale 4,000 365.27 1,461,080
2021-01-04 Desouza Francis A (President and CEO) Sale 3,000 370.51 1,111,533
2020-12-15 Flatley Jay T (Director) Sale 4,000 348.84 1,395,360
2020-12-14 Hoyt Aimee L (SVP, Chief People Officer) Sale 354 345.00 122,130
2020-12-10 Ronaghi Mostafa (SVP, Entrepreneurial Devlopmt) Sale 5,000 338.83 1,694,175
2020-12-07 Tousi Susan H (SVP Product Development) Sale 300 349.01 104,704
2020-12-04 Tousi Susan H (SVP Product Development) Sale 200 350.00 70,000
2020-12-01 Tousi Susan H (SVP Product Development) Sale 100 325.00 32,500
2020-12-01 Dadswell Charles (SVP & General Counsel) Sale 1,694 323.86 548,618
2020-12-01 Desouza Francis A (President and CEO) Sale 3,000 328.50 985,509
2020-12-01 Flatley Jay T (Director) Sale 4,000 323.94 1,295,740
2020-11-30 Ragusa Robert P (SVP, Global Quality & Ops) Sale 2,890 315.39 911,465
2020-11-18 Mcginnis Karen K (VP, Chief Accounting Officer) Sale 218 300.00 65,400
2020-11-17 Flatley Jay T (Director) Sale 3,000 297.37 892,110
2020-11-06 Hoyt Aimee L (SVP, Chief People Officer) Sale 215 310.10 66,671
2020-11-06 Febbo Phillip G. (SVP Chief Medical Officer) Sale 155 310.10 48,065
2020-11-06 Mcginnis Karen K (VP, Chief Accounting Officer) Sale 312 310.10 96,751
2020-11-03 Flatley Jay T (Director) Sale 3,000 297.50 892,515
2020-11-02 Dadswell Charles (SVP & General Counsel) Sale 121 298.00 36,058
2020-11-02 Desouza Francis A (President and CEO) Sale 3,000 300.05 900,156
2020-10-20 Flatley Jay T (Director) Sale 4,000 322.48 1,289,920
2020-10-12 Tousi Susan H (SVP Product Development) Sale 200 350.00 70,000
2020-10-07 Tousi Susan H (SVP Product Development) Sale 100 325.00 32,500
2020-10-07 Flatley Jay T (Director) Sale 1,000 324.01 324,010
2020-10-06 Flatley Jay T (Director) Sale 3,000 317.79 953,370
2020-10-01 Dadswell Charles (SVP & General Counsel) Sale 121 312.82 37,851
2020-10-01 Desouza Francis A (President and CEO) Sale 3,000 309.80 929,396
2020-09-15 Flatley Jay T (Director) Sale 4,000 355.22 1,420,880
2020-09-09 Tousi Susan H (SVP Product Development) Sale 200 350.00 70,000
2020-09-08 Tousi Susan H (SVP Product Development) Sale 100 336.00 33,600
2020-09-01 Van Oene Mark (SVP Chief Commercial Officer) Sale 625 355.71 222,320
2020-09-01 Dadswell Charles (SVP & General Counsel) Sale 1,687 355.35 599,475
2020-09-01 Desouza Francis A (President and CEO) Sale 3,000 352.51 1,057,524
2020-09-01 Flatley Jay T (Director) Sale 4,000 355.35 1,421,400
2020-08-31 Ragusa Robert P (SVP, Global Quality & Ops) Sale 5,000 355.19 1,775,954
2020-08-18 Flatley Jay T (Director) Sale 4,000 354.03 1,416,120
2020-08-10 Mcginnis Karen K (VP, Chief Accounting Officer) Sale 1,856 357.01 662,610
2020-08-05 Tousi Susan H (SVP Product Development) Sale 800 398.70 318,960
2020-08-04 Hoyt Aimee L (SVP, Chief People Officer) Sale 29 397.73 11,534
2020-08-04 Flatley Jay T (Director) Sale 4,000 397.73 1,590,920
2020-08-03 Van Oene Mark (SVP Chief Commercial Officer) Sale 625 385.43 240,893
2020-08-03 Dadswell Charles (SVP & General Counsel) Sale 121 385.19 46,607
2020-08-03 Desouza Francis A (President and CEO) Sale 3,000 389.73 1,169,187
2020-07-21 Flatley Jay T (Director) Sale 4,000 399.00 1,596,000
2020-07-20 Tousi Susan H (SVP Product Development) Sale 500 400.00 200,000
2020-07-07 Flatley Jay T (Director) Sale 4,000 370.22 1,480,880
2020-07-01 Van Oene Mark (SVP Chief Commercial Officer) Sale 625 368.84 230,524
2020-07-01 Dadswell Charles (SVP & General Counsel) Sale 121 369.26 44,680
2020-07-01 Desouza Francis A (President and CEO) Sale 3,000 366.11 1,098,339
2020-06-16 Flatley Jay T (Director) Sale 4,000 354.93 1,419,720
2020-06-15 Ragusa Robert P (SVP, Global Quality & Ops) Sale 5,000 340.52 1,702,625
2020-06-08 Hoyt Aimee L (SVP, Chief People Officer) Sale 191 350.94 67,029
2020-06-02 Flatley Jay T (Director) Sale 4,000 364.40 1,457,600
2020-06-01 Van Oene Mark (SVP Chief Commercial Officer) Sale 625 361.75 226,095
2020-06-01 Dadswell Charles (SVP & General Counsel) Sale 1,686 362.60 611,343
2020-06-01 Desouza Francis A (President and CEO) Sale 3,000 362.10 1,086,303
2020-05-28 Tousi Susan H (SVP Product Development) Sale 600 375.00 225,000

Insider trading activities including stock purchases, stock sales, and option exercises of ILMN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Illumina, Inc. (symbol ILMN, CIK number 1110803) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.